Paul Johannet is an Oncology physician affiliated with Memorial Sloan Kettering Cancer Center. OpenAlex indexes 64 publications with 980 citations (h-index 15).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Clinical impact of MSH3 loss-of-function alterations in patients treated with immune checkpoint blockade across cancer types.
Journal of Clinical Oncology
2026 - Molecular Lineages of Sporadic Mismatch Repair–Deficient Colorectal Cancer
Clinical Cancer Research
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Marc Ladanyi, MD
Memorial Sloan Kettering Cancer Center
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Murray Brennan, MD
Memorial Sloan Kettering Cancer Center
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”